The metabolic fate of [C-14]clenbuterol was studied in male and female
Wistar rats. After a single oral dose of 200 mu g/kg [C-14]clenbutero
l, in an 8-day study period, approximately 60% of the radioactivity wa
s eliminated in urine; 20 and 30% of the radioactivity was excreted in
feces by male and female rats, respectively. HPLC coupled to on-line
radioactivity detection allowed the separation and quantitation of cle
nbuterol metabolites, some of which were found to be poorly stable in
urine. Most of the urinary and fecal metabolites of clenbuterol were i
solated and identified using various MS techniques. Analytical methods
were also developed to establish the metabolic profiles in feces and
tissues, up to 72 hr after clenbuterol administration. Clenbuterol was
mainly metabolized by N-dealkylation (secondary amine), as well as N-
oxidation and sulfate conjugation (primary amine). Gender-related diff
erences in the rates of clenbuterol N-dealkylation were observed. 4-N-
Hydroxylamine was the major metabolite detected in urine, whereas more
than one half of the radioactivity in feces was associated with clenb
uterol sulfamate.